伊普塔科潘用于冷凝固蛋白疾病:一个病例报告与文献综述
Baozhi Fang1, Hongbin Lu2, Xiao Yu1
1Department of Hematology, Affiliated Suzhou Hospital of Nanjing Medical University (Suzhou Municipal Hospital), Suzhou, China.
Frontiers in immunology
|October 20, 2025
概括
一种新的补充C3抑制剂,伊普塔科潘,在其他疗法失败时,有效地治疗了淋巴瘤次要的冷凝聚素疾病 (CAD). 这种方法快速控制了血解和改善了血红蛋白水平,显示了持续的缓解,没有不良事件.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 感冒凝聚素疾病 (CAD) 是一种罕见的自身免疫血液溶解性贫血.
- 管理具有挑战性,特别是在不能容忍Rituximab,Bendamustine或Zanubrutinib等标准治疗的患者中.
- 失控的血液溶解显著影响患者的生活质量和结果.
研究的目的:
- 报告一个成功治疗耐火性冷凝蛋白疾病 (CAD) 的病例.
- 为了评估iptacopan在CAD的联合治疗中的疗效和安全性.
- 评估血液溶解的快速控制和血红蛋白水平的改善.
主要方法:
- 一名患有淋巴细胞淋巴瘤相关的CAD的患者,不能容忍先前的治疗方法,接受了与环胺和德克萨米他结合的伊普塔科潘.
- 血解,血红蛋白水平,胆红素水平和不良事件都被监测.
- 对治疗的反应在4个月的随访期间进行了评估.
主要成果:
- 伊普塔科潘联合治疗在一周内快速控制了血液溶解,实现了输血独立性.
- 血红蛋白水平在第7周从67g/L显著增加到101g/L.
- 胆红素水平正常化,在4个月的随访期间没有报告任何不良事件,这表明持续缓解.
结论:
- 伊普塔科潘作为补充C3抑制剂,为冷凝素疾病 (CAD) 提供了一个有前途的治疗选择.
- 这种组合疗法在缓解血液溶解和改善贫血方面表现出快速和持续的疗效.
- 需要进行进一步的临床试验,以探索伊普塔科班在CAD和其他补充介导疾病中的更广泛的治疗潜力.
更多相关视频
09:29Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
11.9K
06:57Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
2.9K
相关概念视频
01:26Tonsillitis II: Management
396
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
396
02:45Blood Transfusion and Agglutination
14.0K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
14.0K
01:15Transcytosis of IgG
4.0K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.0K